The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, successfully concluded a five-day National Capacity Building Training Programme for Drug Enforcement Officers, Quality Control Personnel and drug manufacturers of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) drugs. The programme was organized from 24th to 28th November 2025 with the objective of strengthening national capabilities in quality assurance, standardization and regulatory compliance in the ASU&H drug sector.

The training programme featured a comprehensive blend of expert lectures, demonstrations and field visits. During the first two days, participants attended detailed technical sessions on NABL Accreditation, Quality Management Systems, Good Manufacturing Practices, Pharmacognostic, Physico-chemical and Phytochemical Evaluation and Quality Control of Herbal Drugs. On the third day, sessions on Shelf-life Studies and Regulatory Frameworks were followed by exposure visits to leading manufacturing units including Dr. Willmar Schwabe India Pvt. Ltd., Noida and Hamdard Laboratories, Ghaziabad. The fourth day focused on Microbiological and Pharmacological Evaluation, Regulatory Aspects and hands-on laboratory-based training, along with a visit to an Herbal Garden. The final day included lectures on Pharmacopoeia, Metal & Mineral Drug Standardization and Modern Instrumentation used in ASU&H drug quality control.

A total of 37 participants representing regulatory authorities, research councils, pharmaceutical industries and academic institutions from across the country joined the programme. The training enabled participants to gain first-hand knowledge on the latest advancements in quality testing and standardization practices within the Indian traditional medicine sector.

The valedictory session was graced by Prof. (Dr.) B. L. Mehra, Chairperson, National Commission for Indian System of Medicine, Ministry of Ayush, as Chief Guest. Also present were Dr. Jai Prakash, Senior Principal Scientific Officer and Officer-in-Charge, Pharmacovigilance Programme of India (PvPI), Indian Pharmacopoeia Commission; Dr. Ravinder Singh, Director, Food Safety and Standards Authority of India; and Dr. Raman Mohan Singh, Director, PCIM&H. The dignitaries emphasized the significance of rigorous quality control, global standards and scientific validation in strengthening the credibility and acceptance of Indian traditional medicine systems.

Participants expressed high appreciation for the programme, noting that the combination of theoretical sessions, practical training and field exposure greatly enhanced their understanding of Pharmacopoeial Standards, Good Manufacturing Practices and related regulatory frameworks. The initiative is expected to contribute significantly to the ongoing efforts toward building a robust national quality assurance ecosystem for ASU&H drugs.

***

 

(Release ID: 2196092) Visitor Counter : 90